COLUMBIA, S.C. (AP) - A pharmaceutical plant in South Carolina has announced a $215 million expansion, that will create 380 new jobs.
Nephron Pharmaceuticals Corp., in a news release Friday, said the expansion would include adding new office, warehouse and vaccine production space at its plant in Lexington County. The projected new jobs would be created by 2024, The State reported.
“Thanks to our partnerships with state and local officials, and the trust they have placed in us, we have been able to provide life-saving medications to patients around the world and establish ourselves as the global leader in what we do,” Nephron CEO Lou Kennedy said in the release.
Nephron develops and produces generic inhalation solutions and suspension products, including those used to treat severe respiratory distress symptoms associated with COVID-19, the company said.
The company has invested $313 million in its facility in West Columbia/Cayce, and has created more than 1,800 full- and part-time jobs over the last five years, the release said.
Please read our comment policy before commenting.